Structural requirements for efficient prion protein conversion: Cofactors may promote a conversion-competent structure for PrPC

Prion

Volumn 4, Issue 4, 2010, Pages 235-243

  Gill, Andrew C ^a   Agarwal, Sonya ^a   Pinheiro, Teresa J T ^b   Graham, James F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Cell free conversion assay; Cofactor; Fibrillization; Loop region; Stability; Structure

Indexed keywords

PRION PROTEIN;

AMINO ACID SEQUENCE; NOTE; PRION DISEASE; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; SCRAPIE;

MAMMALIA;

EID: 78650196956     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.4.4.13394     Document Type: Note

References (75)

1. Weissmann C. Thoughts on mammalian prion strains. Folia Neuropathol 2009; 47:5-8.
2. Fasano C, Campana V, Zurzolo C. Prions: protein only or something more? Overview of potential prion cofactors. J Mol Neurosci 2006; 29:195-214. (Pubitemid 44684495)
3. Mahal SP, Baker CA, Demczyk CA, Smith EW, Julius C, Weissmann C. Prion strain discrimination in cell culture: The cell panel assay. Proc Natl Acad Sci USA 2007; 104:20908-13.
4. Abid K, Morales R, Soto C. Cellular factors implicated in prion replication. Febs Lett 2010; 584:2409-14.
5. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, et al. Synthetic mammalian prions. Science 2004; 305:673-6.
6. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 2010; 119:177-87.
7. Colby DW, Giles K, Legname G, Wille H, Baskakov IV, DeArmond SJ, et al. Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci USA 2009; 106:20417-22.
8. Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285:14083-7.
9. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem 2005; 280:26873-9. (Pubitemid 41040721)
10. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104:9741-6.
11. Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003; 425:717-20.
12. Wang F, Wang XH, Yuan CG, Ma JY. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5.
13. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810-3. (Pubitemid 32588105)
14. Piening N, Weber P, Giese A, Kretzschmar H. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein. Biochem Bioph Res Co 2005; 326:339-43.
15. Ohhashi Y, Kihara M, Naiki H, Goto Y. Ultrasonication-induced amyloid fibril formation of beta(2)-microglobulin. J Biol Chem 2005; 280:32843-8.
16. Stathopulos PB, Scholz GA, Hwang YM, Rumfeldt JAO, Lepock JR, Meiering EM. Sonication of proteins causes formation of aggregates that resemble amyloid. Protein Sci 2004; 13:3017-27.
17. Kirby L, Hope J. Cell-free conversion of prion proteins. In: Lehmann S, Grassi J, Eds. Techniques in Prion Research - Methods and Tools in Biosciences and Medicine. Basel: Birkhauser 2004.
18. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-4.
19. Kirby L, Birkett CR, Rudyk H, Gilbert IH, Hope J. In vitro cell-free conversion of bacterial recombinant PrP to Prp(res) as a model for conversion. J Gen Virol 2003; 84:1013-20.
20. Graham JF, Agarwal S, Kurian D, Kirby L, Pinheiro TJT, Gill AC. Low density subcellular fractions enhance disease-specific prion protein misfolding. J Biol Chem 2010; 285:9868-80.
21. Kirby L, Agarwal S, Graham JF, Goldmann W, Gill AC. Inverse correlation of thermal lability and conversion efficiency for five prion protein polymorphic variants. Biochemistry-US 2010; 49:1448-59.
22. Birkett CR, Hennion RM, Bembridge DA, Clarke MC, Chree A, Bruce ME, et al. Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 2001; 20:3351-8.
23. Breydo L, Makarava N, Baskakov IV. Methods for conversion of prion protein into amyloid fibrils. Methods Mol Biol 2008; 459:105-15.
24. Moore RA, Vorberg I, Priola SA. Species barriers in prion diseases - brief review. Arch Virol 2005; 187-202.
25. Herrmann LM, Caughey B. The importance of the disulfide bond in prion protein conversion. Neuroreport 1998; 9:2457-61. (Pubitemid 28387130)
26. Kazlauskaite J, Young A, Gardner CE, Macpherson JV, Venien-Bryan C, Pinheiro TJT. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells. Biochem Bioph Res Co 2005; 328:292-305.
27. Baskakov IV, Legname G, Gryczynski Z, Prusiner SB. The peculiar nature of unfolding of the human prion protein. Protein Sci 2004; 13:586-95.
28. Goldmann W. PrP genetics in ruminant transmissible spongiform encephalopathies. Vet Res 2008; 39.
29. Goldmann W, Houston F, Stewart P, Perucchini M, Foster J, Hunter N. Ovine prion protein variant A(136) R(154)L(168)Q(171) increases resistance to experimental challenge with bovine spongiform encephalopathy agent. J Gen Virol 2006; 87:3741-5.
30. Pres. J Gen Virol 2006; 87:3747-51.
31. Rezaei H, Eghiaian F, Perez J, Doublet B, Choiset Y, Haertle T, et al. Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J Mol Biol 2005; 347:665-79.
32. Robinson PJ, Pinheiro TJT. The unfolding of the prion protein sheds light on the mechanisms of prion susceptibility and species barrier. Biochemistry-US 2009; 48:8551-8.
33. Fitzmaurice TJ, Burke DF, Hopkins L, Yang SJ, Yu SL, Sy MS, et al. The stability and aggregation of ovine prion protein associated with classical and atypical scrapie correlates with the ease of unwinding of helix-2. Biochem J 2008; 409:367-75. (Pubitemid 351184955)
34. Bujdoso R, Burke DF, Thackray AM. Structural differences between allelic variants of the ovine prion protein revealed by molecular dynamics simulations. Proteins 2005; 61:840-9.
35. Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, Warren RJ, et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 2006; 314:133-6.
36. Gossert AD, Bonjour S, Lysek DA, Fiorito F, Wuthrich K. Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci USA 2005; 102:646-50.
37. Christen B, Perez DR, Hornemann S, Wuthrich K. NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171. J Mol Biol 2008; 383:306-12.
38. Di Bari MA, Chianini F, Vaccari G, Esposito E, Conte M, Eaton SL, et al. The bank vole (Myodes glareolus) as a sensitive bioassay for sheep scrapie. J Gen Virol 2008; 89:2975-85.
39. Piening N, Nonno R, Di Bari M, Walter S, Windl O, Agrimi U, et al. Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo. J Biol Chem 2006; 281:9373-84. (Pubitemid 43864654)
40. Agrimi U, Nonno R, Dell'Omo G, Di Bari MA, Conte M, Chiappini B, et al. Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles. PloS Patho 2008; 4:1000113.
41. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci USA 2009; 106:304-9.
42. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, Schwarz P, et al. A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 2010; 120:2590-9.
43. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 1997; 94:10069-74.
44. Scott MR, Safar J, Telling G, Nguyen O, Groth D, Torchia M, et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc Natl Acad Sci USA 1997; 94:14279-84.
45. Guest WC, Cashman NR, Plotkin SS. Electrostatics in the stability and misfolding of the prion protein: salt bridges, self energy and solvation. Biochem Cell Biol 2010; 88:371-81.
46. Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 2009; 5:1000535.
47. van der Kamp MW, Daggett V. The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 2009; 22:461-8.
48. Luhken G, Buschmann A, Brandt H, Eiden M, Groschup MH, Erhardt G. Epidemiological and genetical differences between classical and atypical scrapie cases. Vet Res 2007; 38:65-80.
49. Simmons MM, Konold T, Simmons HA, Spencer YI, Lockey R, Spiropoulos J, et al. Experimental transmission of atypical scrapie to sheep. BMC Vet Res 2007; 3:20.
50. Foster J, Toovey L, McKenzie C, Chong A, Parnham D, Drummond D, et al. Atypical scrapie in a sheep in a closed UK flock with endemic classical natural scrapie. Vet Rec 2008; 162:723-4.
51. Bocharova OV, Breydo L, Salnikov VV, Gill AC, Baskakov IV. Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob disease. Protein Sci 2005; 14:1222-32. (Pubitemid 40577802)
52. Ma J, Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 2001; 98:14955-60. (Pubitemid 34013951)
53. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001; 314:1209-25.
54. Rieger R, Edenhofer F, Lasmezas CI, Weiss S. The human 37 kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nature Med 1997; 3:1383-8. (Pubitemid 28011039)
55. Parkyn CJ, Vermeulen EG, Mootoosamy RC, Sunyach C, Jacobsen C, Oxvig C, et al. LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J Cell Sci 2008; 121:773-83.
56. Taylor DR, Whitehouse IJ, Hooper NM. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathog 2009; 5:e1000666.
57. Brimacombe DB, Bennett AD, Wusteman FS, Gill AC, Dann JC, Bostock CJ. Characterization and polyanion-binding properties of purified recombinant prion protein. Biochem J 1999; 342:605-13.
58. Gabus C, Auxilien S, Pechoux C, Dormont D, Swietnicki W, Morillas M, et al. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J Mol Biol 2001; 307:1011-21.
59. Sanghera N, Pinheiro TJ. Binding of prion protein to lipid membranes and implications for prion conversion. J Mol Biol 2002; 315:1241-56.
60. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390:684-7.
61. Rutishauser D, Mertz KD, Moos R, Brunner E, Rulicke T, Calella AM, et al. The comprehensive native interactome of a fully functional tagged prion protein. PLoS One 2009; 4:4446.
62. Nieznanski K. Interactions of prion protein with intracellular proteins: so many partners and no consequences? Cell Mol Neurobiol 2010; 30:653-66.
63. Dumpitak C, Beekes M, Weinmann N, Metzger S, Winklhofer KF, Tatzelt J, et al. The polysaccharide scaffold of PrP 27-30 is a common compound of natural prions and consists of alpha-linked polyglucose. Biol Chem 2005; 386:1149-55. (Pubitemid 41705369)
64. Panza G, Stohr J, Birkmann E, Riesner D, Willbold D, Baba O, et al. Aggregation and amyloid fibril formation of the prion protein is accelerated in the presence of glycogen. Rejuvenation Res 2008; 11:365-9.
65. Giorgi A, Di Francesco L, Principe S, Mignogna G, Sennels L, Mancone C, et al. Proteomic profiling of PrP27-30-enriched preparations extracted from the brain of hamsters with experimental scrapie. Proteomics 2009; 9:3802-14.
66. Petrakis S, Malinowska A, Dadlez M, Sklaviadis T. Identification of proteins co-purifying with scrapie infectivity. J Proteomics 2009; 72:690-4.
67. Moore RA, Timmes A, Wilmarth PA, Priola SA. Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations. Proteomics 2010; 10:2858-69.
68. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry-US 2010; 49:3928-34.
69. Wong C, Xiong LW, Horiuchi M, Raymond L, Wehrly K, Chesebro B, et al. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J 2001; 20:377-86.
70. Sanghera N, Swann MJ, Ronan G, Pinheiro TJ. Insight into early events in the aggregation of the prion protein on lipid membranes. Biochim Biophys Acta 2009; 1788:2245-51.
71. Murayama Y, Yoshioka M, Yokoyama T, Iwamaru Y, Imamura M, Masujin K, et al. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci Lett 2007; 413:270-3.
72. Faria TQ, Knapp S, Ladenstein R, Macanita AL, Santos H. Protein stabilisation by compatible solutes: effect of mannosylglycerate on unfolding thermodynamics and activity of ribonuclease A. Chembiochem 2003; 4:734-41.
73. Tuite M, Stojanovski K, Ness F, Merritt G, Koloteva-Levine N. Cellular factors important for the de novo formation of yeast prions. Biochem Soc Trans 2008; 36:1083-7.
74. c interacts with molecular chaperones of the Hsp60 family. J Virol 1996; 70:4724-8.
75. DebBurman SK, Raymond GJ, Caughey B, Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997; 94:13938-43.